“Black seed (Nigella sativa) as an adjuvant therapy in the treatment of patients with rheumatoid arthritis Clinical trial” (2022) Journal of Pharmaceutical Negative Results, 13(4), pp. 1141–1146. doi:10.47750/pnr.2022.13.04.159.